nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—ABCB1—Methylprednisolone—multiple sclerosis	0.0615	0.0978	CbGbCtD
Nisoldipine—CYP3A4—Fingolimod—multiple sclerosis	0.0572	0.0909	CbGbCtD
Nisoldipine—CYP3A7—Dexamethasone—multiple sclerosis	0.0477	0.0758	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0477	0.0758	CbGbCtD
Nisoldipine—ABCB1—Mitoxantrone—multiple sclerosis	0.0449	0.0714	CbGbCtD
Nisoldipine—ABCB1—Betamethasone—multiple sclerosis	0.04	0.0636	CbGbCtD
Nisoldipine—ABCB1—Prednisolone—multiple sclerosis	0.0395	0.0628	CbGbCtD
Nisoldipine—ABCB1—Prednisone—multiple sclerosis	0.0373	0.0593	CbGbCtD
Nisoldipine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0369	0.0586	CbGbCtD
Nisoldipine—CYP3A5—Dexamethasone—multiple sclerosis	0.0358	0.0568	CbGbCtD
Nisoldipine—CYP3A4—Triamcinolone—multiple sclerosis	0.0279	0.0444	CbGbCtD
Nisoldipine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0269	0.0428	CbGbCtD
Nisoldipine—CYP3A4—Betamethasone—multiple sclerosis	0.024	0.0381	CbGbCtD
Nisoldipine—CYP3A4—Prednisolone—multiple sclerosis	0.0236	0.0376	CbGbCtD
Nisoldipine—ABCB1—Dexamethasone—multiple sclerosis	0.0233	0.037	CbGbCtD
Nisoldipine—CYP3A4—Prednisone—multiple sclerosis	0.0223	0.0355	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—multiple sclerosis	0.0187	0.0297	CbGbCtD
Nisoldipine—CYP3A4—Dexamethasone—multiple sclerosis	0.0139	0.0222	CbGbCtD
Nisoldipine—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000402	0.00135	CcSEcCtD
Nisoldipine—Hypotension—Mitoxantrone—multiple sclerosis	0.000401	0.00135	CcSEcCtD
Nisoldipine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.0004	0.00135	CcSEcCtD
Nisoldipine—Visual impairment—Betamethasone—multiple sclerosis	0.000399	0.00134	CcSEcCtD
Nisoldipine—Visual impairment—Dexamethasone—multiple sclerosis	0.000399	0.00134	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000396	0.00133	CcSEcCtD
Nisoldipine—Angioedema—Prednisolone—multiple sclerosis	0.000394	0.00133	CcSEcCtD
Nisoldipine—Myocardial infarction—Prednisone—multiple sclerosis	0.000393	0.00132	CcSEcCtD
Nisoldipine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000391	0.00132	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000391	0.00132	CcSEcCtD
Nisoldipine—Malaise—Prednisolone—multiple sclerosis	0.000389	0.00131	CcSEcCtD
Nisoldipine—Dysgeusia—Triamcinolone—multiple sclerosis	0.000389	0.00131	CcSEcCtD
Nisoldipine—Nausea—Cladribine—multiple sclerosis	0.000388	0.00131	CcSEcCtD
Nisoldipine—Vertigo—Prednisolone—multiple sclerosis	0.000388	0.0013	CcSEcCtD
Nisoldipine—Syncope—Prednisolone—multiple sclerosis	0.000387	0.0013	CcSEcCtD
Nisoldipine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000386	0.0013	CcSEcCtD
Nisoldipine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000383	0.00129	CcSEcCtD
Nisoldipine—Somnolence—Mitoxantrone—multiple sclerosis	0.000382	0.00128	CcSEcCtD
Nisoldipine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000379	0.00128	CcSEcCtD
Nisoldipine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000378	0.00127	CcSEcCtD
Nisoldipine—Asthma—Methotrexate—multiple sclerosis	0.000376	0.00127	CcSEcCtD
Nisoldipine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000373	0.00126	CcSEcCtD
Nisoldipine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000368	0.00124	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000367	0.00124	CcSEcCtD
Nisoldipine—Alopecia—Betamethasone—multiple sclerosis	0.000366	0.00123	CcSEcCtD
Nisoldipine—Alopecia—Dexamethasone—multiple sclerosis	0.000366	0.00123	CcSEcCtD
Nisoldipine—Diarrhoea—Azathioprine—multiple sclerosis	0.000363	0.00122	CcSEcCtD
Nisoldipine—Discomfort—Prednisolone—multiple sclerosis	0.000363	0.00122	CcSEcCtD
Nisoldipine—Angioedema—Triamcinolone—multiple sclerosis	0.000363	0.00122	CcSEcCtD
Nisoldipine—Angioedema—Methylprednisolone—multiple sclerosis	0.000362	0.00122	CcSEcCtD
Nisoldipine—Malaise—Triamcinolone—multiple sclerosis	0.000358	0.0012	CcSEcCtD
Nisoldipine—Malaise—Methylprednisolone—multiple sclerosis	0.000357	0.0012	CcSEcCtD
Nisoldipine—Vertigo—Triamcinolone—multiple sclerosis	0.000357	0.0012	CcSEcCtD
Nisoldipine—Syncope—Triamcinolone—multiple sclerosis	0.000356	0.0012	CcSEcCtD
Nisoldipine—Vertigo—Methylprednisolone—multiple sclerosis	0.000356	0.0012	CcSEcCtD
Nisoldipine—Syncope—Methylprednisolone—multiple sclerosis	0.000355	0.00119	CcSEcCtD
Nisoldipine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000354	0.00119	CcSEcCtD
Nisoldipine—Oedema—Prednisolone—multiple sclerosis	0.000352	0.00119	CcSEcCtD
Nisoldipine—Dysuria—Methotrexate—multiple sclerosis	0.000352	0.00118	CcSEcCtD
Nisoldipine—Dizziness—Azathioprine—multiple sclerosis	0.000351	0.00118	CcSEcCtD
Nisoldipine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000349	0.00117	CcSEcCtD
Nisoldipine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000348	0.00117	CcSEcCtD
Nisoldipine—Shock—Prednisolone—multiple sclerosis	0.000347	0.00117	CcSEcCtD
Nisoldipine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000346	0.00117	CcSEcCtD
Nisoldipine—Cough—Triamcinolone—multiple sclerosis	0.000346	0.00117	CcSEcCtD
Nisoldipine—Tachycardia—Prednisolone—multiple sclerosis	0.000344	0.00116	CcSEcCtD
Nisoldipine—Urticaria—Mitoxantrone—multiple sclerosis	0.000341	0.00115	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000341	0.00115	CcSEcCtD
Nisoldipine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000339	0.00114	CcSEcCtD
Nisoldipine—Myalgia—Triamcinolone—multiple sclerosis	0.000338	0.00114	CcSEcCtD
Nisoldipine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000337	0.00113	CcSEcCtD
Nisoldipine—Myalgia—Methylprednisolone—multiple sclerosis	0.000337	0.00113	CcSEcCtD
Nisoldipine—Anxiety—Methylprednisolone—multiple sclerosis	0.000336	0.00113	CcSEcCtD
Nisoldipine—Rash—Azathioprine—multiple sclerosis	0.000335	0.00113	CcSEcCtD
Nisoldipine—Dermatitis—Azathioprine—multiple sclerosis	0.000335	0.00113	CcSEcCtD
Nisoldipine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000334	0.00112	CcSEcCtD
Nisoldipine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000334	0.00112	CcSEcCtD
Nisoldipine—Discomfort—Triamcinolone—multiple sclerosis	0.000334	0.00112	CcSEcCtD
Nisoldipine—Discomfort—Methylprednisolone—multiple sclerosis	0.000333	0.00112	CcSEcCtD
Nisoldipine—Headache—Azathioprine—multiple sclerosis	0.000333	0.00112	CcSEcCtD
Nisoldipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000331	0.00448	CbGpPWpGaD
Nisoldipine—Dry mouth—Triamcinolone—multiple sclerosis	0.00033	0.00111	CcSEcCtD
Nisoldipine—Angioedema—Dexamethasone—multiple sclerosis	0.000329	0.00111	CcSEcCtD
Nisoldipine—Angioedema—Betamethasone—multiple sclerosis	0.000329	0.00111	CcSEcCtD
Nisoldipine—Stomatitis—Methotrexate—multiple sclerosis	0.000327	0.0011	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000326	0.0011	CcSEcCtD
Nisoldipine—Confusional state—Methylprednisolone—multiple sclerosis	0.000326	0.0011	CcSEcCtD
Nisoldipine—Malaise—Betamethasone—multiple sclerosis	0.000325	0.00109	CcSEcCtD
Nisoldipine—Malaise—Dexamethasone—multiple sclerosis	0.000325	0.00109	CcSEcCtD
Nisoldipine—Oedema—Triamcinolone—multiple sclerosis	0.000324	0.00109	CcSEcCtD
Nisoldipine—Vertigo—Dexamethasone—multiple sclerosis	0.000324	0.00109	CcSEcCtD
Nisoldipine—Vertigo—Betamethasone—multiple sclerosis	0.000324	0.00109	CcSEcCtD
Nisoldipine—Syncope—Betamethasone—multiple sclerosis	0.000323	0.00109	CcSEcCtD
Nisoldipine—Syncope—Dexamethasone—multiple sclerosis	0.000323	0.00109	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—multiple sclerosis	0.000322	0.00108	CcSEcCtD
Nisoldipine—CACNA1C—Alzheimers Disease—APOE—multiple sclerosis	0.000321	0.00436	CbGpPWpGaD
Nisoldipine—Haematuria—Methotrexate—multiple sclerosis	0.00032	0.00108	CcSEcCtD
Nisoldipine—CACNA1S—Axon guidance—PRNP—multiple sclerosis	0.00032	0.00433	CbGpPWpGaD
Nisoldipine—Shock—Triamcinolone—multiple sclerosis	0.000319	0.00107	CcSEcCtD
Nisoldipine—Insomnia—Prednisolone—multiple sclerosis	0.000319	0.00107	CcSEcCtD
Nisoldipine—Alopecia—Prednisone—multiple sclerosis	0.000318	0.00107	CcSEcCtD
Nisoldipine—Shock—Methylprednisolone—multiple sclerosis	0.000318	0.00107	CcSEcCtD
Nisoldipine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000317	0.00106	CcSEcCtD
Nisoldipine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000317	0.00106	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—multiple sclerosis	0.000316	0.00106	CcSEcCtD
Nisoldipine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000316	0.00106	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisolone—multiple sclerosis	0.000316	0.00106	CcSEcCtD
Nisoldipine—Tachycardia—Triamcinolone—multiple sclerosis	0.000316	0.00106	CcSEcCtD
Nisoldipine—Nausea—Azathioprine—multiple sclerosis	0.000315	0.00106	CcSEcCtD
Nisoldipine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000315	0.00106	CcSEcCtD
Nisoldipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000315	0.00427	CbGpPWpGaD
Nisoldipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000315	0.00427	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000315	0.00427	CbGpPWpGaD
Nisoldipine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000313	0.00105	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000312	0.00105	CcSEcCtD
Nisoldipine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000311	0.00421	CbGpPWpGaD
Nisoldipine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000311	0.00421	CbGpPWpGaD
Nisoldipine—Myalgia—Betamethasone—multiple sclerosis	0.000307	0.00103	CcSEcCtD
Nisoldipine—Myalgia—Dexamethasone—multiple sclerosis	0.000307	0.00103	CcSEcCtD
Nisoldipine—Anxiety—Betamethasone—multiple sclerosis	0.000306	0.00103	CcSEcCtD
Nisoldipine—Anxiety—Dexamethasone—multiple sclerosis	0.000306	0.00103	CcSEcCtD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000305	0.00414	CbGpPWpGaD
Nisoldipine—Discomfort—Betamethasone—multiple sclerosis	0.000303	0.00102	CcSEcCtD
Nisoldipine—Discomfort—Dexamethasone—multiple sclerosis	0.000303	0.00102	CcSEcCtD
Nisoldipine—Hypotension—Methylprednisolone—multiple sclerosis	0.000302	0.00102	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—multiple sclerosis	0.000299	0.00101	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000295	0.000993	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000294	0.000991	CcSEcCtD
Nisoldipine—Oedema—Betamethasone—multiple sclerosis	0.000294	0.000989	CcSEcCtD
Nisoldipine—Oedema—Dexamethasone—multiple sclerosis	0.000294	0.000989	CcSEcCtD
Nisoldipine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000294	0.000988	CcSEcCtD
Nisoldipine—Insomnia—Triamcinolone—multiple sclerosis	0.000293	0.000986	CcSEcCtD
Nisoldipine—Insomnia—Methylprednisolone—multiple sclerosis	0.000292	0.000984	CcSEcCtD
Nisoldipine—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000292	0.00395	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000292	0.00395	CbGpPWpGaD
Nisoldipine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000291	0.000979	CcSEcCtD
Nisoldipine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000291	0.000979	CcSEcCtD
Nisoldipine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00029	0.000977	CcSEcCtD
Nisoldipine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00029	0.000976	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—multiple sclerosis	0.00029	0.000976	CcSEcCtD
Nisoldipine—Anaemia—Prednisone—multiple sclerosis	0.00029	0.000975	CcSEcCtD
Nisoldipine—Shock—Betamethasone—multiple sclerosis	0.000289	0.000973	CcSEcCtD
Nisoldipine—Shock—Dexamethasone—multiple sclerosis	0.000289	0.000973	CcSEcCtD
Nisoldipine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000289	0.000972	CcSEcCtD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000288	0.0039	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000288	0.0039	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—IL1B—multiple sclerosis	0.000287	0.0039	CbGpPWpGaD
Nisoldipine—Tachycardia—Betamethasone—multiple sclerosis	0.000287	0.000965	CcSEcCtD
Nisoldipine—Tachycardia—Dexamethasone—multiple sclerosis	0.000287	0.000965	CcSEcCtD
Nisoldipine—Angioedema—Prednisone—multiple sclerosis	0.000287	0.000964	CcSEcCtD
Nisoldipine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000285	0.000959	CcSEcCtD
Nisoldipine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000285	0.000957	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000284	0.00385	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000284	0.00385	CbGpPWpGaD
Nisoldipine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000284	0.000956	CcSEcCtD
Nisoldipine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000284	0.000956	CcSEcCtD
Nisoldipine—Malaise—Prednisone—multiple sclerosis	0.000283	0.000952	CcSEcCtD
Nisoldipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000282	0.00383	CbGpPWpGaD
Nisoldipine—Vertigo—Prednisone—multiple sclerosis	0.000282	0.000948	CcSEcCtD
Nisoldipine—Syncope—Prednisone—multiple sclerosis	0.000281	0.000946	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—multiple sclerosis	0.000281	0.000945	CcSEcCtD
Nisoldipine—Anorexia—Dexamethasone—multiple sclerosis	0.00028	0.000943	CcSEcCtD
Nisoldipine—Anorexia—Betamethasone—multiple sclerosis	0.00028	0.000943	CcSEcCtD
Nisoldipine—Urticaria—Prednisolone—multiple sclerosis	0.00028	0.000942	CcSEcCtD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000277	0.00375	CbGpPWpGaD
Nisoldipine—Loss of consciousness—Prednisone—multiple sclerosis	0.000276	0.000927	CcSEcCtD
Nisoldipine—Hypotension—Dexamethasone—multiple sclerosis	0.000275	0.000924	CcSEcCtD
Nisoldipine—Hypotension—Betamethasone—multiple sclerosis	0.000275	0.000924	CcSEcCtD
Nisoldipine—CACNB2—Axon guidance—PRNP—multiple sclerosis	0.000274	0.00372	CbGpPWpGaD
Nisoldipine—Rash—Mitoxantrone—multiple sclerosis	0.000271	0.000911	CcSEcCtD
Nisoldipine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00027	0.00091	CcSEcCtD
Nisoldipine—Chills—Methotrexate—multiple sclerosis	0.00027	0.000909	CcSEcCtD
Nisoldipine—Headache—Mitoxantrone—multiple sclerosis	0.000269	0.000905	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000268	0.000901	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000268	0.000901	CcSEcCtD
Nisoldipine—Arthralgia—Prednisone—multiple sclerosis	0.000267	0.000898	CcSEcCtD
Nisoldipine—Myalgia—Prednisone—multiple sclerosis	0.000267	0.000898	CcSEcCtD
Nisoldipine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000267	0.000898	CcSEcCtD
Nisoldipine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000266	0.000896	CcSEcCtD
Nisoldipine—Anxiety—Prednisone—multiple sclerosis	0.000266	0.000895	CcSEcCtD
Nisoldipine—Alopecia—Methotrexate—multiple sclerosis	0.000266	0.000895	CcSEcCtD
Nisoldipine—Insomnia—Betamethasone—multiple sclerosis	0.000266	0.000894	CcSEcCtD
Nisoldipine—Insomnia—Dexamethasone—multiple sclerosis	0.000266	0.000894	CcSEcCtD
Nisoldipine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000264	0.000888	CcSEcCtD
Nisoldipine—Paraesthesia—Betamethasone—multiple sclerosis	0.000264	0.000888	CcSEcCtD
Nisoldipine—Discomfort—Prednisone—multiple sclerosis	0.000264	0.000888	CcSEcCtD
Nisoldipine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000263	0.00357	CbGpPWpGaD
Nisoldipine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00026	0.000873	CcSEcCtD
Nisoldipine—CACNA1D—Axon guidance—PRNP—multiple sclerosis	0.000259	0.00352	CbGpPWpGaD
Nisoldipine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000259	0.000871	CcSEcCtD
Nisoldipine—Dyspepsia—Betamethasone—multiple sclerosis	0.000259	0.000871	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000259	0.00351	CbGpPWpGaD
Nisoldipine—Urticaria—Triamcinolone—multiple sclerosis	0.000257	0.000866	CcSEcCtD
Nisoldipine—Urticaria—Methylprednisolone—multiple sclerosis	0.000257	0.000864	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—multiple sclerosis	0.000257	0.000864	CcSEcCtD
Nisoldipine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000256	0.000862	CcSEcCtD
Nisoldipine—Oedema—Prednisone—multiple sclerosis	0.000256	0.000861	CcSEcCtD
Nisoldipine—Decreased appetite—Betamethasone—multiple sclerosis	0.000256	0.00086	CcSEcCtD
Nisoldipine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000256	0.00086	CcSEcCtD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000255	0.00346	CbGpPWpGaD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000255	0.00346	CbGpPWpGaD
Nisoldipine—Nausea—Mitoxantrone—multiple sclerosis	0.000255	0.000858	CcSEcCtD
Nisoldipine—Shock—Prednisone—multiple sclerosis	0.000252	0.000847	CcSEcCtD
Nisoldipine—Tachycardia—Prednisone—multiple sclerosis	0.00025	0.000841	CcSEcCtD
Nisoldipine—CACNA1S—Axon guidance—PTPRC—multiple sclerosis	0.000249	0.00337	CbGpPWpGaD
Nisoldipine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000247	0.000833	CcSEcCtD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000247	0.00335	CbGpPWpGaD
Nisoldipine—Anorexia—Prednisone—multiple sclerosis	0.000244	0.000821	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000244	0.00331	CbGpPWpGaD
Nisoldipine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000243	0.000818	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—multiple sclerosis	0.000242	0.000815	CcSEcCtD
Nisoldipine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000242	0.000815	CcSEcCtD
Nisoldipine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000242	0.000815	CcSEcCtD
Nisoldipine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000239	0.000803	CcSEcCtD
Nisoldipine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000238	0.000801	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—multiple sclerosis	0.000236	0.000795	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—multiple sclerosis	0.000236	0.000792	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—multiple sclerosis	0.000235	0.000789	CcSEcCtD
Nisoldipine—CACNB2—Neuronal System—BCHE—multiple sclerosis	0.000234	0.00317	CbGpPWpGaD
Nisoldipine—Urticaria—Betamethasone—multiple sclerosis	0.000234	0.000786	CcSEcCtD
Nisoldipine—Urticaria—Dexamethasone—multiple sclerosis	0.000234	0.000786	CcSEcCtD
Nisoldipine—CACNA1D—Alzheimers Disease—IL1B—multiple sclerosis	0.000233	0.00316	CbGpPWpGaD
Nisoldipine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000233	0.000785	CcSEcCtD
Nisoldipine—Dizziness—Prednisolone—multiple sclerosis	0.000233	0.000784	CcSEcCtD
Nisoldipine—Body temperature increased—Betamethasone—multiple sclerosis	0.000232	0.000782	CcSEcCtD
Nisoldipine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000232	0.000782	CcSEcCtD
Nisoldipine—Insomnia—Prednisone—multiple sclerosis	0.000232	0.000779	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisone—multiple sclerosis	0.00023	0.000773	CcSEcCtD
Nisoldipine—Pruritus—Triamcinolone—multiple sclerosis	0.000229	0.000771	CcSEcCtD
Nisoldipine—Cough—Methotrexate—multiple sclerosis	0.000229	0.00077	CcSEcCtD
Nisoldipine—Pruritus—Methylprednisolone—multiple sclerosis	0.000229	0.000769	CcSEcCtD
Nisoldipine—CACNA1S—Developmental Biology—PRNP—multiple sclerosis	0.000228	0.00309	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—PRNP—multiple sclerosis	0.000228	0.00309	CbGpPWpGaD
Nisoldipine—Dyspepsia—Prednisone—multiple sclerosis	0.000225	0.000758	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—multiple sclerosis	0.000223	0.000751	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—multiple sclerosis	0.000223	0.000751	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—multiple sclerosis	0.000223	0.000751	CcSEcCtD
Nisoldipine—Decreased appetite—Prednisone—multiple sclerosis	0.000223	0.000749	CcSEcCtD
Nisoldipine—Rash—Prednisolone—multiple sclerosis	0.000222	0.000747	CcSEcCtD
Nisoldipine—Dermatitis—Prednisolone—multiple sclerosis	0.000222	0.000747	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000221	0.003	CbGpPWpGaD
Nisoldipine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000221	0.000744	CcSEcCtD
Nisoldipine—Headache—Prednisolone—multiple sclerosis	0.000221	0.000742	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—multiple sclerosis	0.00022	0.000742	CcSEcCtD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00022	0.00298	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—MAPK1—multiple sclerosis	0.000219	0.00297	CbGpPWpGaD
Nisoldipine—Confusional state—Methotrexate—multiple sclerosis	0.000216	0.000726	CcSEcCtD
Nisoldipine—Dizziness—Triamcinolone—multiple sclerosis	0.000214	0.000721	CcSEcCtD
Nisoldipine—Dizziness—Methylprednisolone—multiple sclerosis	0.000214	0.000719	CcSEcCtD
Nisoldipine—CACNB2—Axon guidance—PTPRC—multiple sclerosis	0.000213	0.00289	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000212	0.00287	CbGpPWpGaD
Nisoldipine—Feeling abnormal—Prednisone—multiple sclerosis	0.000211	0.00071	CcSEcCtD
Nisoldipine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000211	0.00286	CbGpPWpGaD
Nisoldipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00021	0.00285	CbGpPWpGaD
Nisoldipine—Nausea—Prednisolone—multiple sclerosis	0.000209	0.000704	CcSEcCtD
Nisoldipine—CACNA1S—Alzheimers Disease—TNF—multiple sclerosis	0.000208	0.00283	CbGpPWpGaD
Nisoldipine—Pruritus—Betamethasone—multiple sclerosis	0.000208	0.0007	CcSEcCtD
Nisoldipine—Pruritus—Dexamethasone—multiple sclerosis	0.000208	0.0007	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000207	0.000696	CcSEcCtD
Nisoldipine—CACNA1C—Alzheimers Disease—IL1B—multiple sclerosis	0.000205	0.00278	CbGpPWpGaD
Nisoldipine—Rash—Triamcinolone—multiple sclerosis	0.000204	0.000687	CcSEcCtD
Nisoldipine—Dermatitis—Triamcinolone—multiple sclerosis	0.000204	0.000687	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—multiple sclerosis	0.000204	0.000686	CcSEcCtD
Nisoldipine—Rash—Methylprednisolone—multiple sclerosis	0.000204	0.000686	CcSEcCtD
Nisoldipine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000204	0.000685	CcSEcCtD
Nisoldipine—Urticaria—Prednisone—multiple sclerosis	0.000203	0.000684	CcSEcCtD
Nisoldipine—Headache—Triamcinolone—multiple sclerosis	0.000203	0.000683	CcSEcCtD
Nisoldipine—Headache—Methylprednisolone—multiple sclerosis	0.000202	0.000681	CcSEcCtD
Nisoldipine—Body temperature increased—Prednisone—multiple sclerosis	0.000202	0.000681	CcSEcCtD
Nisoldipine—CACNA1D—Axon guidance—PTPRC—multiple sclerosis	0.000202	0.00274	CbGpPWpGaD
Nisoldipine—Diarrhoea—Betamethasone—multiple sclerosis	0.000201	0.000677	CcSEcCtD
Nisoldipine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000201	0.000677	CcSEcCtD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.0002	0.00272	CbGpPWpGaD
Nisoldipine—Hypotension—Methotrexate—multiple sclerosis	0.0002	0.000673	CcSEcCtD
Nisoldipine—CACNB2—Developmental Biology—PRNP—multiple sclerosis	0.000196	0.00265	CbGpPWpGaD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000195	0.000656	CcSEcCtD
Nisoldipine—Dizziness—Betamethasone—multiple sclerosis	0.000194	0.000654	CcSEcCtD
Nisoldipine—Dizziness—Dexamethasone—multiple sclerosis	0.000194	0.000654	CcSEcCtD
Nisoldipine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000194	0.00263	CbGpPWpGaD
Nisoldipine—Insomnia—Methotrexate—multiple sclerosis	0.000193	0.000651	CcSEcCtD
Nisoldipine—Nausea—Triamcinolone—multiple sclerosis	0.000192	0.000647	CcSEcCtD
Nisoldipine—CACNB2—Metabolism—SRM—multiple sclerosis	0.000192	0.00261	CbGpPWpGaD
Nisoldipine—Paraesthesia—Methotrexate—multiple sclerosis	0.000192	0.000646	CcSEcCtD
Nisoldipine—Nausea—Methylprednisolone—multiple sclerosis	0.000192	0.000646	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000192	0.0026	CbGpPWpGaD
Nisoldipine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000191	0.00259	CbGpPWpGaD
Nisoldipine—Dyspnoea—Methotrexate—multiple sclerosis	0.000191	0.000642	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—multiple sclerosis	0.00019	0.00064	CcSEcCtD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.00019	0.00257	CbGpPWpGaD
Nisoldipine—Hypersensitivity—Prednisone—multiple sclerosis	0.000189	0.000635	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—multiple sclerosis	0.000188	0.000634	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000187	0.00253	CbGpPWpGaD
Nisoldipine—Decreased appetite—Methotrexate—multiple sclerosis	0.000186	0.000626	CcSEcCtD
Nisoldipine—Rash—Betamethasone—multiple sclerosis	0.000185	0.000624	CcSEcCtD
Nisoldipine—Rash—Dexamethasone—multiple sclerosis	0.000185	0.000624	CcSEcCtD
Nisoldipine—Dermatitis—Dexamethasone—multiple sclerosis	0.000185	0.000623	CcSEcCtD
Nisoldipine—Dermatitis—Betamethasone—multiple sclerosis	0.000185	0.000623	CcSEcCtD
Nisoldipine—CACNA1D—Developmental Biology—PRNP—multiple sclerosis	0.000185	0.00251	CbGpPWpGaD
Nisoldipine—Headache—Betamethasone—multiple sclerosis	0.000184	0.00062	CcSEcCtD
Nisoldipine—Headache—Dexamethasone—multiple sclerosis	0.000184	0.00062	CcSEcCtD
Nisoldipine—CACNA1D—Metabolism—SRM—multiple sclerosis	0.000182	0.00247	CbGpPWpGaD
Nisoldipine—Pruritus—Prednisone—multiple sclerosis	0.000181	0.000609	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000178	0.00242	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—MAPK1—multiple sclerosis	0.000178	0.00241	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—PTPRC—multiple sclerosis	0.000177	0.00241	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—PTPRC—multiple sclerosis	0.000177	0.0024	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000177	0.0024	CbGpPWpGaD
Nisoldipine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000176	0.000593	CcSEcCtD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000176	0.00239	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000176	0.00238	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000176	0.00238	CbGpPWpGaD
Nisoldipine—Diarrhoea—Prednisone—multiple sclerosis	0.000175	0.000589	CcSEcCtD
Nisoldipine—Nausea—Dexamethasone—multiple sclerosis	0.000175	0.000587	CcSEcCtD
Nisoldipine—Nausea—Betamethasone—multiple sclerosis	0.000175	0.000587	CcSEcCtD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000173	0.00235	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000173	0.00235	CbGpPWpGaD
Nisoldipine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000171	0.00232	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.00017	0.00231	CbGpPWpGaD
Nisoldipine—Urticaria—Methotrexate—multiple sclerosis	0.00017	0.000572	CcSEcCtD
Nisoldipine—Dizziness—Prednisone—multiple sclerosis	0.000169	0.00057	CcSEcCtD
Nisoldipine—CACNA1D—Alzheimers Disease—TNF—multiple sclerosis	0.000169	0.0023	CbGpPWpGaD
Nisoldipine—Body temperature increased—Methotrexate—multiple sclerosis	0.000169	0.000569	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000168	0.00228	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—PRNP—multiple sclerosis	0.000163	0.00221	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000163	0.00221	CbGpPWpGaD
Nisoldipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000162	0.0022	CbGpPWpGaD
Nisoldipine—Rash—Prednisone—multiple sclerosis	0.000161	0.000543	CcSEcCtD
Nisoldipine—Dermatitis—Prednisone—multiple sclerosis	0.000161	0.000543	CcSEcCtD
Nisoldipine—Headache—Prednisone—multiple sclerosis	0.00016	0.00054	CcSEcCtD
Nisoldipine—CACNA1C—Metabolism—SRM—multiple sclerosis	0.00016	0.00217	CbGpPWpGaD
Nisoldipine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000158	0.00053	CcSEcCtD
Nisoldipine—CACNA1C—Alzheimers Disease—MAPK1—multiple sclerosis	0.000156	0.00212	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000154	0.00209	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000153	0.00208	CbGpPWpGaD
Nisoldipine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000152	0.00207	CbGpPWpGaD
Nisoldipine—Nausea—Prednisone—multiple sclerosis	0.000152	0.000512	CcSEcCtD
Nisoldipine—CACNB2—Developmental Biology—PTPRC—multiple sclerosis	0.000152	0.00206	CbGpPWpGaD
Nisoldipine—Pruritus—Methotrexate—multiple sclerosis	0.000151	0.000509	CcSEcCtD
Nisoldipine—CACNA1C—Alzheimers Disease—TNF—multiple sclerosis	0.000149	0.00202	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000148	0.002	CbGpPWpGaD
Nisoldipine—Diarrhoea—Methotrexate—multiple sclerosis	0.000146	0.000492	CcSEcCtD
Nisoldipine—CACNA1D—Developmental Biology—PTPRC—multiple sclerosis	0.000144	0.00195	CbGpPWpGaD
Nisoldipine—Dizziness—Methotrexate—multiple sclerosis	0.000141	0.000476	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000138	0.00187	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000136	0.00184	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000136	0.00184	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP27B1—multiple sclerosis	0.000135	0.00184	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP24A1—multiple sclerosis	0.000135	0.00184	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000135	0.00183	CbGpPWpGaD
Nisoldipine—Rash—Methotrexate—multiple sclerosis	0.000135	0.000454	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—multiple sclerosis	0.000135	0.000453	CcSEcCtD
Nisoldipine—Headache—Methotrexate—multiple sclerosis	0.000134	0.000451	CcSEcCtD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000134	0.00181	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000134	0.00181	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000133	0.0018	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.00013	0.00177	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.00013	0.00177	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP27B1—multiple sclerosis	0.000128	0.00174	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP24A1—multiple sclerosis	0.000128	0.00174	CbGpPWpGaD
Nisoldipine—Nausea—Methotrexate—multiple sclerosis	0.000127	0.000428	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000127	0.00172	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—PTPRC—multiple sclerosis	0.000127	0.00172	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000124	0.00168	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GPC5—multiple sclerosis	0.000124	0.00168	CbGpPWpGaD
Nisoldipine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000123	0.00167	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GPC5—multiple sclerosis	0.000117	0.00159	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000117	0.00159	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000116	0.00158	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000115	0.00156	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP27B1—multiple sclerosis	0.000113	0.00153	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP24A1—multiple sclerosis	0.000113	0.00153	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—TYK2—multiple sclerosis	0.000111	0.00151	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000105	0.00143	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GPC5—multiple sclerosis	0.000103	0.0014	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—RRM1—multiple sclerosis	0.000103	0.00139	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—SRM—multiple sclerosis	9.79e-05	0.00133	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—RRM1—multiple sclerosis	9.72e-05	0.00132	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	9.71e-05	0.00132	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—TYK2—multiple sclerosis	9.53e-05	0.00129	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	9.44e-05	0.00128	CbGpPWpGaD
Nisoldipine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.18e-05	0.00124	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—POMC—multiple sclerosis	9.07e-05	0.00123	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—TYK2—multiple sclerosis	9.03e-05	0.00122	CbGpPWpGaD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.93e-05	0.00121	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—MMP9—multiple sclerosis	8.76e-05	0.00119	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.64e-05	0.00117	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—RRM1—multiple sclerosis	8.54e-05	0.00116	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	8.42e-05	0.00114	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8.4e-05	0.00114	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	8.39e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—TYK2—multiple sclerosis	7.94e-05	0.00108	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—TYK2—multiple sclerosis	7.93e-05	0.00108	CbGpPWpGaD
Nisoldipine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	7.81e-05	0.00106	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	7.67e-05	0.00104	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MMP9—multiple sclerosis	7.51e-05	0.00102	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.44e-05	0.00101	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MMP9—multiple sclerosis	7.11e-05	0.000964	CbGpPWpGaD
Nisoldipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.08e-05	0.00096	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—MAPK1—multiple sclerosis	7.08e-05	0.00096	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—SRM—multiple sclerosis	7.08e-05	0.00096	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	6.9e-05	0.000936	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	6.9e-05	0.000936	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	6.84e-05	0.000928	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—MAPK1—multiple sclerosis	6.84e-05	0.000928	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	6.82e-05	0.000925	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—TYK2—multiple sclerosis	6.8e-05	0.000923	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.75e-05	0.000915	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.75e-05	0.000915	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.75e-05	0.000915	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.56e-05	0.00089	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	6.56e-05	0.00089	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.55e-05	0.000888	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.54e-05	0.000888	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—TYK2—multiple sclerosis	6.44e-05	0.000874	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6.42e-05	0.00087	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GPC5—multiple sclerosis	6.31e-05	0.000856	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MMP9—multiple sclerosis	6.25e-05	0.000848	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MMP9—multiple sclerosis	6.25e-05	0.000847	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.11e-05	0.000829	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.11e-05	0.000829	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MAPK1—multiple sclerosis	6.07e-05	0.000823	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—BCHE—multiple sclerosis	5.89e-05	0.000799	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.77e-05	0.000783	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MAPK1—multiple sclerosis	5.75e-05	0.000779	CbGpPWpGaD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.74e-05	0.000779	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—TYK2—multiple sclerosis	5.66e-05	0.000768	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—BCHE—multiple sclerosis	5.58e-05	0.000757	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—STAT3—multiple sclerosis	5.56e-05	0.000754	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—IL6—multiple sclerosis	5.44e-05	0.000738	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MMP9—multiple sclerosis	5.36e-05	0.000727	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—SRM—multiple sclerosis	5.34e-05	0.000724	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.32e-05	0.000721	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—RRM1—multiple sclerosis	5.23e-05	0.000709	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.18e-05	0.000702	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—TGFB1—multiple sclerosis	5.15e-05	0.000699	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MMP9—multiple sclerosis	5.07e-05	0.000688	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MAPK1—multiple sclerosis	5.05e-05	0.000685	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MAPK1—multiple sclerosis	5.05e-05	0.000685	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.99e-05	0.000676	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.99e-05	0.000676	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.97e-05	0.000674	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—BCHE—multiple sclerosis	4.9e-05	0.000665	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—TNF—multiple sclerosis	4.81e-05	0.000652	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—STAT3—multiple sclerosis	4.76e-05	0.000646	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—IL6—multiple sclerosis	4.66e-05	0.000632	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.58e-05	0.000621	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.56e-05	0.000619	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—STAT3—multiple sclerosis	4.51e-05	0.000612	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MMP9—multiple sclerosis	4.46e-05	0.000605	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—IL6—multiple sclerosis	4.42e-05	0.000599	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—TGFB1—multiple sclerosis	4.42e-05	0.000599	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MAPK1—multiple sclerosis	4.33e-05	0.000587	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SRM—multiple sclerosis	4.26e-05	0.000578	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—TGFB1—multiple sclerosis	4.18e-05	0.000567	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—TNF—multiple sclerosis	4.12e-05	0.000559	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MAPK1—multiple sclerosis	4.1e-05	0.000556	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—STAT3—multiple sclerosis	3.96e-05	0.000538	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.95e-05	0.000536	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—TNF—multiple sclerosis	3.9e-05	0.00053	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—IL6—multiple sclerosis	3.88e-05	0.000526	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—IL6—multiple sclerosis	3.88e-05	0.000526	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.78e-05	0.000513	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.76e-05	0.00051	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.76e-05	0.00051	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—TGFB1—multiple sclerosis	3.67e-05	0.000498	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MAPK1—multiple sclerosis	3.6e-05	0.000489	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—APOE—multiple sclerosis	3.55e-05	0.000481	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GPC5—multiple sclerosis	3.44e-05	0.000467	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—TNF—multiple sclerosis	3.43e-05	0.000465	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—APOE—multiple sclerosis	3.36e-05	0.000455	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—IL6—multiple sclerosis	3.33e-05	0.000451	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SRM—multiple sclerosis	3.29e-05	0.000446	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—IL6—multiple sclerosis	3.15e-05	0.000427	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.05e-05	0.000414	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—POMC—multiple sclerosis	3.05e-05	0.000413	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3e-05	0.000407	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3e-05	0.000407	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—BCHE—multiple sclerosis	3e-05	0.000407	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—APOE—multiple sclerosis	2.95e-05	0.0004	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.94e-05	0.000398	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—POMC—multiple sclerosis	2.88e-05	0.000391	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—RRM1—multiple sclerosis	2.85e-05	0.000387	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—ALB—multiple sclerosis	2.78e-05	0.000377	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—IL6—multiple sclerosis	2.77e-05	0.000375	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.75e-05	0.000373	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.63e-05	0.000357	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—ALB—multiple sclerosis	2.63e-05	0.000357	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.62e-05	0.000356	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.57e-05	0.000349	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—POMC—multiple sclerosis	2.53e-05	0.000344	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.45e-05	0.000332	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.32e-05	0.000314	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.32e-05	0.000314	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ALB—multiple sclerosis	2.31e-05	0.000313	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.28e-05	0.000309	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.17e-05	0.000294	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.12e-05	0.000288	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—APOE—multiple sclerosis	1.81e-05	0.000245	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.77e-05	0.00024	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.76e-05	0.000238	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.65e-05	0.000223	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.64e-05	0.000222	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—POMC—multiple sclerosis	1.55e-05	0.00021	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.52e-05	0.000206	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ALB—multiple sclerosis	1.41e-05	0.000192	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.38e-05	0.000188	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.31e-05	0.000177	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000177	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—POMC—multiple sclerosis	1.12e-05	0.000152	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ALB—multiple sclerosis	1.02e-05	0.000139	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.01e-05	0.000137	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—APOE—multiple sclerosis	9.85e-06	0.000134	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—POMC—multiple sclerosis	8.46e-06	0.000115	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—APOE—multiple sclerosis	7.87e-06	0.000107	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ALB—multiple sclerosis	7.72e-06	0.000105	CbGpPWpGaD
Nisoldipine—Clevidipine—BCHE—multiple sclerosis	6.78e-06	1	CrCbGaD
Nisoldipine—CYP1A2—Metabolism—POMC—multiple sclerosis	6.76e-06	9.16e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ALB—multiple sclerosis	6.16e-06	8.36e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—APOE—multiple sclerosis	6.07e-06	8.23e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—POMC—multiple sclerosis	5.22e-06	7.07e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.75e-06	6.45e-05	CbGpPWpGaD
